Document Detail


Effect of multiple oral doses of androgenic anabolic steroids on endurance performance and serum indices of physical stress in healthy male subjects.
MedLine Citation:
PMID:  16896724     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Anabolic androgenic steroids (AAS) are doping agents that are mostly used for improvement of strength and muscle hypertrophy. In some sports, athletes reported that the intake of AAS is associated with a better recovery, a higher training load capacity and therefore an increase in physical and mental performances. The purpose of this study was to evaluate, the effect of multiple doses of AAS on different physiological parameters that could indirectly relate the physical state of athletes during a hard endurance training program. In a double blind settings, three groups (n = 9, 8 and 8) were orally administered placebo, testosterone undecanoate or 19-norandrostenedione, 12 times during 1 month. Serum biomarkers (creatine kinase, ASAT and urea), serum hormone profiles (testosterone, cortisol and LH) and urinary catecholamines (noradrenalin, adrenalin and dopamine) were evaluated during the treatment. Running performance was assessed before and after the intervention phase by means of a standardized treadmill test. None of the measured biochemical variables showed significant impact of AAS on physical stress level. Data from exercise testing on submaximal and maximal level did not reveal any performance differences between the three groups or their response to the treatment. In the present study, no effect of multiple oral doses of AAS on endurance performance or bioserum recovery markers was found.
Authors:
Norbert Baume; Yorck Olaf Schumacher; Pierre-Edouard Sottas; Carlo Bagutti; Michel Cauderay; Patrice Mangin; Martial Saugy
Related Documents :
2676544 - Application of molecular biology in exercise physiology.
2691834 - Dehydration and hyponatremia during triathlons.
9155214 - Creatine is an ergogen for anaerobic exercise.
20086644 - Overuse tendinosis, not tendinitis part 2: applying the new approach to patellar tendin...
3568584 - Haemodynamics during repeated exercise tests with special reference to the 'warm-up' ph...
8718454 - Elusive control.
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't     Date:  2006-08-03
Journal Detail:
Title:  European journal of applied physiology     Volume:  98     ISSN:  1439-6319     ISO Abbreviation:  Eur. J. Appl. Physiol.     Publication Date:  2006 Nov 
Date Detail:
Created Date:  2006-10-18     Completed Date:  2007-01-04     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100954790     Medline TA:  Eur J Appl Physiol     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  329-40     Citation Subset:  IM    
Affiliation:
Laboratoire Suisse d'Analyse du Dopage, Institut Universitaire de Médecine Légale, Ch. des Croisettes 22, 1066, Epalinges, Switzerland. norbaume@gmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Anabolic Agents / pharmacology*
Androgens / pharmacology*
Androstenedione / analogs & derivatives,  pharmacology
Biological Markers
Catecholamines / urine
Double-Blind Method
Exercise Test
Heart Rate / drug effects,  physiology
Hormones / blood
Humans
Hydrocortisone / blood
Lactic Acid / blood
Male
Physical Endurance / drug effects*
Physical Fitness / physiology
Running / physiology
Steroids / pharmacology*
Stress, Psychological / blood*,  urine
Testosterone / pharmacology
Chemical
Reg. No./Substance:
0/Anabolic Agents; 0/Androgens; 0/Biological Markers; 0/Catecholamines; 0/Hormones; 0/Steroids; 50-21-5/Lactic Acid; 50-23-7/Hydrocortisone; 58-22-0/Testosterone; 63-05-8/Androstenedione; 734-32-7/19-norandrostenedione

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The effect of acute exercise on endothelial function following a high-fat meal.
Next Document:  Vagal postganglionic origin of vasoactive intestinal polypeptide (VIP) mediating the vagal tachycard...